Business Wire

Rove Hotels Unveils the Only On-Site Hotel at Expo 2020 Dubai

27.10.2020 13:17:00 EET | Business Wire | Press release

Share

With Expo 2020 Dubai now less than a year away, the eyes of the world are back on this much-awaited event, as it gears up to help shape the future. A homegrown hotel brand that can be found at the heart of communities across Dubai – Rove Hotels made the very special announcement that it will be the only hotel at Expo 2020 Dubai, which will be taking place from 1st October 2021 to 31st March 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005569/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

For those who Rove: Rove Expo 2020, the only on-site hotel at Expo 2020 Dubai, adjacent to Al Wasl Plaza - (Photo : AETOSWire)

A gateway to inspiring experiences of culture, innovation and human excellence at Expo 2020, the Rove Expo 2020 hotel – part of the Rove brand – will feature 312 king, twin and accessible Rover Rooms, as well as 19 Rover suites. Furthermore, the only hotel at Expo 2020 will boast several F&B outlets, including The Daily, a grab & go Rove Café and The Bar, along with a rooftop swimming pool and sundeck overlooking the Al Wasl Plaza, 100% sustainable in-room amenities, a 24-hour gym, prayer rooms, and more.

Marjan Faraidooni, Chief Pavilions and Exhibitions Officer at Expo 2020 Dubai, said, “This is a significant step forward in the development of the Expo 2020 site. An on-site hotel is a great addition to the world-class facilities we are creating to welcome people from all around the world to experience this once-in-a-lifetime event.”

“Rove Expo 2020 will remain as a permanent modern hospitality offering at District 2020, which will evolve into a smart human-centric community as the future of Expo 2020 Dubai. It will support District 2020’s aim to create a mixed-use development and an innovation-driven urban destination that caters to the needs of its future workers, residents and visitors through its diverse community offering,” she added.

The Rove team is even more excited and determined than ever to cater to the diverse needs of visitors from all over the world as the one and only hotel destination inside Expo 2020.

“This exciting hotel will no doubt boost the already huge appeal of such a historical and major event for the UAE, and offer Expo 2020 visitors a new and innovative type of hospitality option at the heart of the Expo site,” said Mr. Ahmad Thani Rashed Al Matrooshi, Board Director of Rove Hotels LLC.

For more information, visit https://www.rovehotels.com/hotel/rove-expo-2020/

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Katch International
Dhara Bhatia,
Engagement Consultant, +971567944126
dhara@katchthis.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye